Skip to content

UFP Technologies UFPT Pre-tax stock-based compensation cost

Pre-tax stock-based compensation cost at other companies

TFX
TeleflexTFX
Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Medtronic logo
MedtronicMDT
Plexus logo
PlexusPLXS

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%
Enterprise value$2.02B-6.0%
P/E27.4×-3.3×
P/S3.1×-0.5×

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's pre-tax stock-based compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's pre-tax stock-based compensation cost?
UFP Technologies (UFPT) reported pre-tax stock-based compensation cost of $2.73M in Q1 2026.
How has UFP Technologies's pre-tax stock-based compensation cost changed year-over-year?
UFP Technologies's pre-tax stock-based compensation cost increased by 23.6% year-over-year, from $2.21M to $2.73M.